Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Initiation of Antiplatelet ThERapy In HeArt TranspLantation: AERIAL Trial

NCT04770012 is registered in ClinicalTrials.gov with Ottawa Heart Institute Research Corporation as lead sponsor.

NCT NCT04770012
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04770012 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Initiation of Antiplatelet ThERapy In HeArt TranspLantation: AERIAL Trial
Lead sponsor
Ottawa Heart Institute Research Corporation
Phase
Phase 3
Overall status
Recruiting
Start date
June 28, 2021
Completion date
March 31, 2029
Enrollment
135 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac allograft vasculopathy, heart transplant